Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bioventus Inc Cl A 4721 EMPEROR BOULEVARD SUITE 100 DURHAM NC 27703 USA

www.bioventus.com Employees: 930 P: 919-474-6700

Sector:

Medical

Description:

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

Key Statistics

Overview:

Market Capitalization, $K 610,791
Enterprise Value, $K 904,841
Shares Outstanding, K 82,763
Annual Sales, $ 573,280 K
Annual Net Income, $ -33,540 K
Last Quarter Sales, $ 138,650 K
Last Quarter Net Income, $ 3,160 K
EBIT, $ 84,980 K
EBITDA, $ 134,540 K
60-Month Beta 0.79
% of Insider Shareholders 33.00%
% of Institutional Shareholders 62.94%
Float, K 55,451
% Float 67.00%
Short Interest 1,807
Short Float 2.18%
Short Volume Ratio 0.10

Growth:

1-Year Return -32.45%
3-Year Return 182.76%
5-Year Return 0.00%
5-Year Revenue Growth 78.50%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.15 on 11/04/25
Next Earnings Date 03/10/26
Earnings Per Share ttm 0.59
EPS Growth vs. Prev Qtr -28.57%
EPS Growth vs. Prev Year 150.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BVS Ratios

Ratio
Price/Earnings ttm 12.76
Price/Earnings forward 28.96
Price/Earnings to Growth N/A
Return-on-Equity % 26.38%
Return-on-Assets % 7.27%
Profit Margin % -5.85%
Debt/Equity 1.56
Price/Sales 1.09
Price/Cash Flow 7.04
Price/Book 3.01
Book Value/Share 2.50
Interest Coverage -0.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar